← Eichor
Study identifier: NCT04898452 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intravenous Antibiotic Treatment at Home

Condition: Infection  ·  Sponsor: Helse Møre og Romsdal HF

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of the study is to develop and evaluate a new model for across services interaction with the use of welfare technology and telemedicine. The model includes innovative and new routines for the exchange of patient information, quality systems and procedures between the municipality and the hospital. This model will first be tested for use in intravenous antibiotic therapy. The results of the study will be used to further develop the service. In the larger context, it is desirable to provide knowledge that is transferable to other diagnostic groups, treatment methods and geographical areas.

This description comes directly from the study's public registry record.

Talk to the study team

Inger Stokke, MSc  ·  +47 41928023  ·  inger.stokke@helse-mr.no

Ann Iren Kjønnøy, MSc  ·  Ann.Iren.Kjonnoy@helse-mr.no

Always discuss trial participation with your own doctor first.

Locations (1)

Helse Møre og Romsdal HF, Kristiansund sjukehus, Medisinsk AvdelingKristiansund, NorwayRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04898452